Literature DB >> 11573967

Inducible RGS2 is a cross-talk regulator for parathyroid hormone signaling in rat osteoblast-like UMR106 cells.

J K Ko1, K H Choi, I S Kim, E K Jung, D H Park.   

Abstract

Parathyroid hormone (PTH) activates dual signal transduction systems via Galphas and Galphaq proteins. We now report a novel mechanism by which "cross-talk" may occur between the Galphas and Galphaq signaling pathways. RGS2 (Regulator of G protein Signaling 2) mRNA was rapidly and transiently increased only by PTH analogs (PTH1-84, 1-34, 1-31, and PTHrP) that activated the Galphas-mediated cAMP/PKA signaling pathway, whereas activation of the Galphaq-mediated Ca(2+)/PKC signaling pathway by PTH3-34 had no effect on RGS2 expression. Treatment of UMR106 cells with nonPTH activators of the cAMP/PKA signaling pathway such as cholera toxin, forskolin, 8-Br-cAMP, and dibutyryl-cAMP also significantly elevated RGS2 mRNA levels, while activator of the Galphaq pathway PMA did not. Pretreatment using the Galphas signaling pathway inhibitors SQ22536 and H89 significantly blocked PTH-induced RGS2 expression, but the Galphaq signaling pathway inhibitor bisindolylmaleimide I had no effect. Therefore, RGS2 expression is governed solely by the Galphas signaling pathway. Additionally, we demonstrate for the first time that RGS2 binds to both Galphas and Galphaq subunits in their transition state (GDP/AlF(-4)-bound) forms, suggesting that RGS2 has the potential to act as a bridge between the cAMP/PKA and Ca(2+)/PKC pathways, and that it may act as a cross-talk regulator for these two PTH signaling pathways. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573967     DOI: 10.1006/bbrc.2001.5692

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy.

Authors:  Claudine G James; C Thomas G Appleton; Veronica Ulici; T Michael Underhill; Frank Beier
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

Review 3.  Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology.

Authors:  Joel Jules; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Prog Mol Biol Transl Sci       Date:  2015-04-27       Impact factor: 3.622

4.  RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.

Authors:  Khalid Chakir; Weizhong Zhu; Sharon Tsang; Anthony Yiu-Ho Woo; Dongmei Yang; Xianhua Wang; Xiaokun Zeng; Man-Hee Rhee; Ulrike Mende; Norimichi Koitabashi; Eiki Takimoto; Kendall J Blumer; Edward G Lakatta; David A Kass; Rui-Ping Xiao
Journal:  J Mol Cell Cardiol       Date:  2011-02-01       Impact factor: 5.000

5.  Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia.

Authors:  Douglas L Jones; Jari M Tuomi; Peter Chidiac
Journal:  Front Physiol       Date:  2012-06-29       Impact factor: 4.566

6.  Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of Gq/11 signaling and vascular contraction.

Authors:  Stanley M Kanai; Alethia J Edwards; Joel G Rurik; Patrick Osei-Owusu; Kendall J Blumer
Journal:  J Biol Chem       Date:  2017-10-03       Impact factor: 5.157

Review 7.  Role of regulator of G protein signaling proteins in bone.

Authors:  David Keinan; Shuying Yang; Robert E Cohen; Xue Yuan; Tongjun Liu; Yi-Ping Li
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

8.  Parathyroid Hormone-Related Protein Promotes Rat Stem Leydig Cell Differentiation.

Authors:  Tiantian Song; Yiyan Wang; Huitao Li; Lanlan Chen; Jianpeng Liu; Xianwu Chen; Xiaojun Li; Xiaoheng Li; Linxi Li; Qingquan Lian; Ren-Shan Ge
Journal:  Front Physiol       Date:  2017-11-13       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.